20 filings · most recent first
TEM 8-K Filings
Tempus Ai Reports Strong Q2 2026 Results And Raises Guidance
Tempus Ai Announces Merger Agreement With Personalis
Tempus Ai Announces Acquisition Of Personalis To Integrate Mrd Technology
Tempus Ai Inc Announces Election Of Directors At 2026 Annual Meeting
Tempus Ai Announces 460M Convertible Senior Notes Offering
Tempus Ai Reports 361 Revenue Growth And Raises 2026 Guidance
Tempus Ai Reports Strong Financial Growth In 2025 And Provides 2026 Guidance
Tempus Ai Reports Strong Preliminary 2025 Financial Results
Tempus Ai Reports Strong Q3 2025 Results With Revenue Growth And Positive
Tempus Ai Announces Resale Of Shares Via Prospectus Supplement
Tempus Ai Announces 750 Million Convertible Notes Offering
Tempus Ai Inc Announces Annual Meeting Results
Tempus Ai Announces Strategic Partnership For Oncology Model Development
Tempus Ai Inc Amends Credit Agreement To Fund Acquisition Of Ambry Genetics
Tempus Ai Reports Strong Preliminary 2024 Results
Tempus Ai Announces Acquisition Of Ambry Genetics
Tempus Ai Reports Strong Q2 2025 Financial Results
Tempus Ai Reports 754 Revenue Growth For Q1 2025
Tempus Ai Reports Q4 And Full Year 2024 Results With Strong Revenue Growth
Tempus Ai Reports Q3 2024 Results And Ambry Genetics Acquisition